Expected and observed life expectancy, loss in expectation of life, and proportion of expected life loss among patients hospitalized acutely for atrial fibrillation or flutter in Australia and New Zealand
| Population . | Expected life expectancy . | Observed life expectancy (95% CI) . | Loss in life expectancy (95% CI) . | Proportion of life lost (95% CI) . |
|---|---|---|---|---|
| Overall | 18.0 | 15.4 (15.2–15.6) | 2.6 (2.4–2.8) | 16.8% (15.7%–17.9%) |
| Age | ||||
| 18–34 years | 46.6 | 44.3 (43.8–44.8) | 2.3 (1.8–2.8) | 4.9% (3.8%–5.9%) |
| 35–49 years | 39.2 | 35.8 (35.4–36.2) | 3.4 (3.0–3.8) | 8.7% (7.7%–9.6%) |
| 50–64 years | 27.1 | 23.8 (23.6–24.1) | 3.3 (3.0–3.6) | 12.1% (11.1%–13.0%) |
| 65–79 years | 15.7 | 12.8 (12.6–13.0) | 2.9 (2.7–3.0) | 18.0% (16.8%–19.1%) |
| ≥80 years | 7.3 | 5.7 (5.6–5.8) | 1.6 (1.5–1.7) | 21.4% (20.1%–22.7%) |
| Sex | ||||
| Female | 16.2 | 13.7 (13.6–13.9) | 2.5 (2.3–2.6) | 17.2% (16.1%–18.3%) |
| Male | 19.7 | 17.0 (16.7–17.2) | 2.7 (2.5–3.0) | 16.4% (15.3%–17.6%) |
| Population . | Expected life expectancy . | Observed life expectancy (95% CI) . | Loss in life expectancy (95% CI) . | Proportion of life lost (95% CI) . |
|---|---|---|---|---|
| Overall | 18.0 | 15.4 (15.2–15.6) | 2.6 (2.4–2.8) | 16.8% (15.7%–17.9%) |
| Age | ||||
| 18–34 years | 46.6 | 44.3 (43.8–44.8) | 2.3 (1.8–2.8) | 4.9% (3.8%–5.9%) |
| 35–49 years | 39.2 | 35.8 (35.4–36.2) | 3.4 (3.0–3.8) | 8.7% (7.7%–9.6%) |
| 50–64 years | 27.1 | 23.8 (23.6–24.1) | 3.3 (3.0–3.6) | 12.1% (11.1%–13.0%) |
| 65–79 years | 15.7 | 12.8 (12.6–13.0) | 2.9 (2.7–3.0) | 18.0% (16.8%–19.1%) |
| ≥80 years | 7.3 | 5.7 (5.6–5.8) | 1.6 (1.5–1.7) | 21.4% (20.1%–22.7%) |
| Sex | ||||
| Female | 16.2 | 13.7 (13.6–13.9) | 2.5 (2.3–2.6) | 17.2% (16.1%–18.3%) |
| Male | 19.7 | 17.0 (16.7–17.2) | 2.7 (2.5–3.0) | 16.4% (15.3%–17.6%) |
CI, confidence interval.
Expected and observed life expectancy, loss in expectation of life, and proportion of expected life loss among patients hospitalized acutely for atrial fibrillation or flutter in Australia and New Zealand
| Population . | Expected life expectancy . | Observed life expectancy (95% CI) . | Loss in life expectancy (95% CI) . | Proportion of life lost (95% CI) . |
|---|---|---|---|---|
| Overall | 18.0 | 15.4 (15.2–15.6) | 2.6 (2.4–2.8) | 16.8% (15.7%–17.9%) |
| Age | ||||
| 18–34 years | 46.6 | 44.3 (43.8–44.8) | 2.3 (1.8–2.8) | 4.9% (3.8%–5.9%) |
| 35–49 years | 39.2 | 35.8 (35.4–36.2) | 3.4 (3.0–3.8) | 8.7% (7.7%–9.6%) |
| 50–64 years | 27.1 | 23.8 (23.6–24.1) | 3.3 (3.0–3.6) | 12.1% (11.1%–13.0%) |
| 65–79 years | 15.7 | 12.8 (12.6–13.0) | 2.9 (2.7–3.0) | 18.0% (16.8%–19.1%) |
| ≥80 years | 7.3 | 5.7 (5.6–5.8) | 1.6 (1.5–1.7) | 21.4% (20.1%–22.7%) |
| Sex | ||||
| Female | 16.2 | 13.7 (13.6–13.9) | 2.5 (2.3–2.6) | 17.2% (16.1%–18.3%) |
| Male | 19.7 | 17.0 (16.7–17.2) | 2.7 (2.5–3.0) | 16.4% (15.3%–17.6%) |
| Population . | Expected life expectancy . | Observed life expectancy (95% CI) . | Loss in life expectancy (95% CI) . | Proportion of life lost (95% CI) . |
|---|---|---|---|---|
| Overall | 18.0 | 15.4 (15.2–15.6) | 2.6 (2.4–2.8) | 16.8% (15.7%–17.9%) |
| Age | ||||
| 18–34 years | 46.6 | 44.3 (43.8–44.8) | 2.3 (1.8–2.8) | 4.9% (3.8%–5.9%) |
| 35–49 years | 39.2 | 35.8 (35.4–36.2) | 3.4 (3.0–3.8) | 8.7% (7.7%–9.6%) |
| 50–64 years | 27.1 | 23.8 (23.6–24.1) | 3.3 (3.0–3.6) | 12.1% (11.1%–13.0%) |
| 65–79 years | 15.7 | 12.8 (12.6–13.0) | 2.9 (2.7–3.0) | 18.0% (16.8%–19.1%) |
| ≥80 years | 7.3 | 5.7 (5.6–5.8) | 1.6 (1.5–1.7) | 21.4% (20.1%–22.7%) |
| Sex | ||||
| Female | 16.2 | 13.7 (13.6–13.9) | 2.5 (2.3–2.6) | 17.2% (16.1%–18.3%) |
| Male | 19.7 | 17.0 (16.7–17.2) | 2.7 (2.5–3.0) | 16.4% (15.3%–17.6%) |
CI, confidence interval.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
